Heartbroken family backs call for more investment into “horrendous disease”

2 min read

A devastated family is appealing for final signatures on our petition calling for greater investment in research into brain tumours before it closes tomorrow (Tuesday 31st October). 

Jade Goldie said: “As a family we have learnt the hard way how we desperately need more funding to research brain tumours. We have so many unanswered questions.” 

Her family knows all too well the heartbreak of losing someone to the disease. Jade’s dad, Brian, died in May 2022, eight months after he was diagnosed with a high-grade glioma.  

Doctors initially thought Brian was suffering with tinnitus and suggested he chewed gum to alleviate his symptoms. Months later, in September 2021, the grandfather-of-15 began to suffer with headaches and fatigue. He developed a tingling in his arm and soon after, lost the feeling down the right-hand side of his body.  

Brian was admitted to hospital with a suspected stroke. An MRI scan showed the aggressive tumour on his brain stem and Brian was given months to live. 

Tony said: “Dad was slurring his speech and seemed confused. We were told that the tumour was inoperable due to where It was growing, and it was aggressive. We were desperate to improve his outcome and asked if there was a clinical trial he could try but there was nothing. His only option was radiotherapy.” 

More than 77,000 people have now signed our petition, and time is running out to achieve the 100,000 signatures we need in the hope of prompting a parliamentary debate. Sign now, if you haven’t already: www.braintumourresearch.org/petition 

Jade added: “There must be kinder treatment options, more treatment options, life-saving treatment options. We believe more can be done and our hope by supporting Brain Tumour Research, is that no other family has to experience the loss of a family member to this horrendous disease.” 

Brian’s wife, Maryann, with Jade and Tony placing a tile in memory of Brian on the Wall of Hope at our Centre of Excellence at Imperial College London. 

Related reading: 

Back to Latest News